======= TNFRSF1B ======= == Gene Information == * **Official Symbol**: TNFRSF1B * **Official Name**: TNF receptor superfamily member 1B * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=7133|7133]] * **UniProt**: [[https://www.uniprot.org/uniprot/P20333|P20333]] * **Interactions**: [[https://thebiogrid.org/search.php?search=TNFRSF1B&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20TNFRSF1B|Open PubMed]] * **OMIM**: [[https://omim.org/entry/191191|Open OMIM]] == Function Summary == * **Entrez Summary**: The protein encoded by this gene is a member of the TNF-receptor superfamily. This protein and TNF-receptor 1 form a heterocomplex that mediates the recruitment of two anti-apoptotic proteins, c-IAP1 and c-IAP2, which possess E3 ubiquitin ligase activity. The function of IAPs in TNF-receptor signalling is unknown, however, c-IAP1 is thought to potentiate TNF-induced apoptosis by the ubiquitination and degradation of TNF-receptor-associated factor 2, which mediates anti-apoptotic signals. Knockout studies in mice also suggest a role of this protein in protecting neurons from apoptosis by stimulating antioxidative pathways. [provided by RefSeq, Jul 2008]. * **UniProt Summary**: Receptor with high affinity for TNFSF2/TNF-alpha and approximately 5-fold lower affinity for homotrimeric TNFSF1/lymphotoxin-alpha. The TRAF1/TRAF2 complex recruits the apoptotic suppressors BIRC2 and BIRC3 to TNFRSF1B/TNFR2. This receptor mediates most of the metabolic effects of TNF-alpha. Isoform 2 blocks TNF-alpha-induced apoptosis, which suggests that it regulates TNF-alpha function by antagonizing its biological activity. {ECO:0000269|PubMed:12370298}. |TNFR c6| |glial cell-neuron signaling| |tumor necrosis factor binding| |tumor necrosis factor receptor superfamily complex| |negative regulation of extracellular matrix constituent secretion| |positive regulation of apoptotic process involved in development| |positive regulation of apoptotic process involved in morphogenesis| |regulation of extracellular matrix constituent secretion| |varicosity| |tumor necrosis factor-activated receptor activity| |negative regulation of extracellular matrix organization| |negative regulation of neuroinflammatory response| |regulation of apoptotic process involved in development| |regulation of apoptotic process involved in morphogenesis| |positive regulation of membrane protein ectodomain proteolysis| |regulation of cytokine secretion involved in immune response| |positive regulation of myelination| |pulmonary valve development| |positive regulation of oligodendrocyte differentiation| |regulation of membrane protein ectodomain proteolysis| |negative regulation of cardiac muscle hypertrophy| |negative regulation of muscle hypertrophy| |regulation of neuroinflammatory response| |regulation of T cell cytokine production| |aortic valve development| |RNA destabilization| |semi-lunar valve development| |regulation of extracellular matrix organization| |regulation of oligodendrocyte differentiation| |positive regulation of glial cell differentiation| |regulation of myelination| |regulation of cardiac muscle hypertrophy| |regulation of muscle hypertrophy| |heart valve development| |positive regulation of nervous system process| |regulation of glial cell differentiation| |positive regulation of gliogenesis| |regulation of T cell mediated immunity| |intrinsic apoptotic signaling pathway in response to DNA damage| |regulation of cytokine production involved in immune response| |regulation of muscle adaptation| |specific granule membrane| |extrinsic apoptotic signaling pathway| |regulation of gliogenesis| |tumor necrosis factor-mediated signaling pathway| |regulation of nervous system process| |negative regulation of inflammatory response| |regulation of production of molecular mediator of immune response| |regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains| |intrinsic apoptotic signaling pathway| |regulation of lymphocyte mediated immunity| |regulation of T cell proliferation| |regulation of adaptive immune response| |regulation of RNA stability| |cellular response to lipopolysaccharide| |cellular response to molecule of bacterial origin| |negative regulation of secretion by cell| |regulation of cytokine secretion| |regulation of leukocyte mediated immunity| |negative regulation of neuron death| |negative regulation of defense response| |regulation of lymphocyte proliferation| |regulation of mononuclear cell proliferation| |cellular response to biotic stimulus| |positive regulation of protein catabolic process| |regulation of leukocyte proliferation| |membrane raft| |negative regulation of secretion| |regulation of muscle system process| |cellular response to tumor necrosis factor| |response to tumor necrosis factor| |aging| |apoptotic signaling pathway| |ubiquitin protein ligase binding| |regulation of neuron death| |response to lipopolysaccharide| |regulation of T cell activation| |response to molecule of bacterial origin| |regulation of inflammatory response| |positive regulation of proteolysis| |negative regulation of response to external stimulus| |positive regulation of cellular catabolic process| |neuronal cell body| |regulation of protein catabolic process| |positive regulation of catabolic process| |regulation of protein secretion| |regulation of immune effector process| |positive regulation of neurogenesis| |negative regulation of transport| |neutrophil degranulation| |neutrophil activation involved in immune response| |regulation of peptide secretion| |inflammatory response| |neutrophil mediated immunity| |cellular response to growth factor stimulus| |neutrophil activation| |granulocyte activation| |leukocyte degranulation| |regulation of lymphocyte activation| |myeloid leukocyte mediated immunity| |cellular response to lipid| |myeloid cell activation involved in immune response| |posttranscriptional regulation of gene expression| |heart development| |response to growth factor| |positive regulation of nervous system development| |positive regulation of cell development| |myeloid leukocyte activation| |regulation of system process| |regulation of leukocyte activation| |leukocyte activation involved in immune response| |cell activation involved in immune response| |regulation of cell activation| |positive regulation of apoptotic process| |positive regulation of programmed cell death| |cytokine-mediated signaling pathway| |response to bacterium| |regulation of cytokine production| |perinuclear region of cytoplasm| |positive regulation of cell death| |regulated exocytosis| |negative regulation of cellular component organization| |regulation of protein transport| |regulation of proteolysis| |regulation of peptide transport| |regulation of establishment of protein localization| |regulation of secretion by cell| |regulation of defense response| |leukocyte mediated immunity| |cellular response to DNA damage stimulus| |exocytosis| |regulation of secretion| |regulation of neurogenesis| |regulation of cellular catabolic process| |response to lipid| |circulatory system development| |apoptotic process| |regulation of nervous system development| |leukocyte activation| |regulation of cell development| |positive regulation of cell differentiation| |regulation of catabolic process| |negative regulation of cell death| |secretion by cell| |cellular response to cytokine stimulus| |regulation of protein localization| |export from cell| |programmed cell death| |cellular response to oxygen-containing compound| |regulation of anatomical structure morphogenesis| |cell activation| |immune effector process| |cell death| |regulation of response to external stimulus| |response to cytokine| |cell-cell signaling| |secretion| |regulation of immune response| |negative regulation of multicellular organismal process| |response to other organism| |response to external biotic stimulus| |response to biotic stimulus| |defense response| |positive regulation of developmental process| |regulation of response to stress| |generation of neurons| |regulation of apoptotic process| |response to oxygen-containing compound| |regulation of programmed cell death| |positive regulation of cellular protein metabolic process| |regulation of cell population proliferation| |negative regulation of response to stimulus| |neurogenesis| |regulation of immune system process| |regulation of cell death| |intracellular signal transduction| |cellular response to stress| |positive regulation of protein metabolic process| |positive regulation of RNA metabolic process| |positive regulation of multicellular organismal process| |regulation of cell differentiation| |regulation of transport| |immune response| |positive regulation of nucleobase-containing compound metabolic process| |extracellular region| |vesicle-mediated transport| |membrane| \\ === CRISPR Data === No hits were found. No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 7534 * **Expression level (log2 read counts)**: 3.67 {{:chemogenomics:nalm6 dist.png?nolink |}}